{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:49:04Z","timestamp":1789703344389,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis patients developing psoriatic arthritis (PsA) are thought to go through different phases. Understanding the underlying events in these phases is crucial to diagnose PsA early. Here, we have characterized the circulating memory T helper (Th) cells in psoriasis patients with or without arthralgia, psoriasis patients who developed PsA during follow-up (subclinical PsA), early PsA patients and healthy controls to elucidate their role in PsA development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used peripheral blood mononuclear cells of sex and age-matched psoriasis patients included in Rotterdam Joint Skin study (<jats:italic>n<\/jats:italic>=22), early PsA patients included in Dutch South West Early Psoriatic Arthritis Cohort (DEPAR) (<jats:italic>n<\/jats:italic>=23) and healthy controls (HC; <jats:italic>n<\/jats:italic>=17). We profiled memory Th cell subsets with flow cytometry and used the machine learning algorithm FlowSOM to interpret the data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three of the 22 psoriasis patients developed PsA during 2-year follow-up. FlowSOM identified 12 clusters of memory Th cells, including Th1, Th2, Th17\/22, and Th17.1 cells. All psoriasis and PsA patients had higher numbers of Th17\/22 than healthy controls. Psoriasis patients without arthralgia had lower numbers of CCR6<jats:sup>-<\/jats:sup>CCR4<jats:sup>+<\/jats:sup>CXCR3<jats:sup>+<\/jats:sup> memory Th cells and higher numbers of CCR6<jats:sup>+<\/jats:sup>CCR4<jats:sup>-<\/jats:sup>CXCR3<jats:sup>-<\/jats:sup>memory Th cells compared to HC. PsA patients had higher numbers of Th2 cells and CCR6<jats:sup>+<\/jats:sup>CCR4<jats:sup>+<\/jats:sup>CXCR3<jats:sup>-<\/jats:sup> cells, but lower numbers of CCR6<jats:sup>+<\/jats:sup>CCR4<jats:sup>+<\/jats:sup>CXCR3<jats:sup>+<\/jats:sup> memory Th cells compared to HC. The number of CCR6<jats:sup>+<\/jats:sup> Th17.1 cells negatively correlated with tender joint counts and the number of CCR6<jats:sup>+<\/jats:sup> Th17 cells positively correlated with skin disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Unsupervised clustering analysis revealed differences in circulating memory Th cells between psoriasis and PsA patients compared to HC; however, no specific subset was identified characterizing subclinical PsA patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-021-02714-5","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T09:03:07Z","timestamp":1642582987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Characterizing memory T helper cells in patients with psoriasis, subclinical, or early psoriatic arthritis using a machine learning algorithm"],"prefix":"10.1186","volume":"24","author":[{"given":"Hannah","family":"den Braanker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wida","family":"Razawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Wervers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Mus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Davelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-040X","authenticated-orcid":false,"given":"Erik","family":"Lubberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"2714_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"key":"2714_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15:153\u201366.","journal-title":"Nat Rev Rheumatol"},{"key":"2714_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/art.41271","volume":"72","author":"X Xu","year":"2020","unstructured":"Xu X, Davelaar N, Mus AM, Asmawidjaja PS, Hazes JMW, Baeten DLP, et al. Interleukin-17A is produced by CD4+ but not CD8+ T cells in synovial fluid following T cell receptor activation and regulates different inflammatory mediators compared to tumor necrosis factor in a model of psoriatic arthritis synovitis. Arthritis Rheum. 2020;72:1303\u201313.","journal-title":"Arthritis Rheum"},{"key":"2714_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8:639\u201346.","journal-title":"Nat Immunol"},{"key":"2714_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cyto.2015.02.002","volume":"74","author":"SM Paulissen","year":"2015","unstructured":"Paulissen SM, van Hamburg JP, Dankers W, Lubberts E. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis. Cytokine. 2015;74:43\u201353.","journal-title":"Cytokine."},{"key":"2714_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni.1770","volume":"10","author":"S Trifari","year":"2009","unstructured":"Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009;10:864\u201371.","journal-title":"Nat Immunol"},{"key":"2714_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts E. The IL-23-IL-17 axis in inflammatory arthritis. Nat Rev Rheumatol. 2015;11:415\u201329.","journal-title":"Nat Rev Rheumatol"},{"key":"2714_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","volume":"35","author":"N Yu","year":"2012","unstructured":"Yu N, Li X, Song W, Li D, Yu D, Zeng X, et al. CD4(+)CD25 (+)CD127 (low\/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012;35:1773\u201380.","journal-title":"Inflammation."},{"key":"2714_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13075-015-0800-5","volume":"17","author":"SM Paulissen","year":"2015","unstructured":"Paulissen SM, van Hamburg JP, Davelaar N, Vroman H, Hazes JM, de Jong PH, et al. CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis. Arthritis Res Ther. 2015;17:344.","journal-title":"Arthritis Res Ther"},{"key":"2714_CR10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/brain\/awy069","volume":"141","author":"J van Langelaar","year":"2018","unstructured":"van Langelaar J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, Spilt IM, Siepman TA, et al. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain. 2018;141:1334\u201349.","journal-title":"Brain."},{"key":"2714_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.20130301","volume":"211","author":"R Ramesh","year":"2014","unstructured":"Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, Quintero MA, et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med. 2014;211:89\u2013104.","journal-title":"J Exp Med"},{"key":"2714_CR12","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4317","volume":"15","author":"H Benham","year":"2013","unstructured":"Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther. 2013;15:R136.","journal-title":"Arthritis Res Ther"},{"key":"2714_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12977-016-0293-6","volume":"13","author":"VS Wacleche","year":"2016","unstructured":"Wacleche VS, Goulet JP, Gosselin A, Monteiro P, Soudeyns H, Fromentin R, et al. New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy. Retrovirology. 2016;13:59.","journal-title":"Retrovirology."},{"key":"2714_CR14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20102516","volume":"208","author":"Q Wan","year":"2011","unstructured":"Wan Q, Kozhaya L, ElHed A, Ramesh R, Carlson TJ, Djuretic IM, et al. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells. J Exp Med. 2011;208:1875\u201387.","journal-title":"J Exp Med"},{"key":"2714_CR15","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1002\/eji.201242648","volume":"42","author":"L Maggi","year":"2012","unstructured":"Maggi L, Santarlasci V, Capone M, Rossi MC, Querci V, Mazzoni A, et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells. Eur J Immunol. 2012;42:3180\u20138.","journal-title":"Eur J Immunol"},{"key":"2714_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen S, Callebaut B, Van Helden MJ, Lambrecht BN, Demeester P, Dhaene T, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A. 2015;87:636\u201345.","journal-title":"Cytometry A"},{"key":"2714_CR17","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/acr.23571","volume":"70","author":"K Wervers","year":"2018","unstructured":"Wervers K, Vis M, Tchetveriko I, Gerards AH, Kok MR, Appels CWY, et al. Burden of psoriatic arthritis according to different definitions of disease activity: comparing minimal disease activity and the disease activity index for psoriatic arthritis. Arthritis Care Res. 2018;70:1764\u201370.","journal-title":"Arthritis Care Res"},{"key":"2714_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum. 2008;59:686\u201391.","journal-title":"Arthritis Rheum"},{"key":"2714_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157:238\u201344.","journal-title":"Dermatologica."},{"key":"2714_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/03009742.2017.1393695","volume":"47","author":"K Wervers","year":"2018","unstructured":"Wervers K, Vis M, Rasappu N, van der Ven M, Tchetverikov I, Kok MR, et al. Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers. Scand J Rheumatol. 2018;47:291\u20134.","journal-title":"Scand J Rheumatol"},{"key":"2714_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12859-016-1083-9","volume":"17","author":"A Azad","year":"2016","unstructured":"Azad A, Rajwa B, Pothen A. flowVS: channel-specific variance stabilization in flow cytometry. BMC Bioinformatics. 2016;17:291.","journal-title":"BMC Bioinformatics"},{"key":"2714_CR22","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics."},{"key":"2714_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/kex323","volume":"56","author":"W Tillett","year":"2017","unstructured":"Tillett W, Charlton R, Nightingale A, Snowball J, Green A, Smith C, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017;56:2109\u201313.","journal-title":"Rheumatology (Oxford)"},{"key":"2714_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045\u201350.","journal-title":"Ann Rheum Dis"},{"key":"2714_CR25","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/cyto.a.23030","volume":"89","author":"LM Weber","year":"2016","unstructured":"Weber LM, Robinson MD. Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data. Cytometry A. 2016;89:1084\u201396.","journal-title":"Cytometry A"},{"key":"2714_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/labinvest.3780242","volume":"81","author":"JB Rottman","year":"2001","unstructured":"Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Investig. 2001;81:335\u201347.","journal-title":"Lab Investig"},{"key":"2714_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13075-021-02532-9","volume":"23","author":"W Dankers","year":"2021","unstructured":"Dankers W, den Braanker H, Paulissen SMJ, van Hamburg JP, Davelaar N, Colin EM, et al. The heterogeneous human memory CCR6+ T helper-17 populations differ in T-bet and cytokine expression but all activate synovial fibroblasts in an IFNgamma-independent manner. Arthritis Res Ther. 2021;23:157.","journal-title":"Arthritis Res Ther"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02714-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T09:06:36Z","timestamp":1642583196000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02714-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2714"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02714-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"5 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants in both studies and healthy controls according to the Declaration of Helsinki. The Rotterdam Joint Skin study was approved by the Medical Research Ethics Committee United at the Maasstad Hospital, Rotterdam (2018-08). The DEPAR study was approved by the local Ethics Committee at Erasmus Medical Center, Rotterdam (2012-549).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}